Linagliptin as add-on to empagliflozin and metformin in patients with type 2 diabetes: Two 24-week randomized, double-blind, double-dummy, parallel-group trials

Tinahones, Francisco J.; Gallwitz, Baptist; Nordaby, Matias; Goetz, Sophia; Maldonado-Lutomirsky, Mario; Woerle, Hans J.; Broedl, Uli C.

dc.contributor.author	Gallwitz, Baptist
dc.date.accessioned	2018-04-17T09:42:48Z
dc.date.available	2018-04-17T09:42:48Z
dc.date.issued	2017
dc.identifier.issn	1463-1326
dc.identifier.uri	http://hdl.handle.net/10900/81457
dc.language.iso	en	de_DE
dc.publisher	Wiley - Blackwell	de_DE
dc.relation.uri	http://dx.doi.org/10.1111/dom.12814	de_DE
dc.rights	info:eu-repo/semantics/closedAccess
dc.subject.ddc	610	de_DE
dc.title	Linagliptin as add-on to empagliflozin and metformin in patients with type 2 diabetes: Two 24-week randomized, double-blind, double-dummy, parallel-group trials	de_DE
dc.type	Article	de_DE
utue.quellen.id	20170815222223_01991
utue.publikation.seiten	266-274	de_DE
utue.personen.roh	Tinahones, Francisco J.
utue.personen.roh	Gallwitz, Baptist
utue.personen.roh	Nordaby, Matias
utue.personen.roh	Goetz, Sophia
utue.personen.roh	Maldonado-Lutomirsky, Mario
utue.personen.roh	Woerle, Hans J.
utue.personen.roh	Broedl, Uli C.
dcterms.isPartOf.ZSTitelID	Diabetes Obesity & Metabolism	de_DE
dcterms.isPartOf.ZS-Issue	2	de_DE
dcterms.isPartOf.ZS-Volume	19	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE